FDA Approves Faricimab for nAMD and Diabetic Macular Edema

The US Food and Drug Administration has approved faricimab, a drug with the potential to reduce the number of injections needed to treat diabetic macular edema and neovascular age-related macular degeneration.
FDA Approvals

Full Story →